148 related articles for article (PubMed ID: 7570321)
1. Beta 1 integrin expression in malignant melanoma predicts occult lymph node metastases.
Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Kim DK; Das Gupta TK
Surgery; 1995 Oct; 118(4):669-73; discussion 673-5. PubMed ID: 7570321
[TBL] [Abstract][Full Text] [Related]
2. Beta 1 integrin expression: a marker of lymphatic metastases in cutaneous malignant melanoma.
Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Das Gupta TK
Anticancer Res; 1996; 16(4B):2321-4. PubMed ID: 8694563
[TBL] [Abstract][Full Text] [Related]
3. Molecular prognostic markers in intermediate-thickness cutaneous malignant melanoma.
Hieken TJ; Ronan SG; Farolan M; Shilkaitis AL; Das Gupta TK
Cancer; 1999 Jan; 85(2):375-82. PubMed ID: 10023705
[TBL] [Abstract][Full Text] [Related]
4. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
Naffouje S; Naffouje R; Bhagwandin S; Salti GI
Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
[TBL] [Abstract][Full Text] [Related]
5. Selective lymph node dissection in patients with intermediate thickness melanoma: our experience.
Cafiero F; Peressini A; Percivale PL; Rainero ML; Faggioni M; Gipponi M; Queirolo P; Nicolo G; Bertoglio S
Anticancer Res; 2000; 20(1B):497-500. PubMed ID: 10769712
[TBL] [Abstract][Full Text] [Related]
6. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
[TBL] [Abstract][Full Text] [Related]
9. Molecular oncogene markers and their significance in cutaneous malignant melanoma.
Konstadoulakis MM; Vezeridis M; Hatziyianni E; Karakousis CP; Cole B; Bland KI; Wanebo HJ
Ann Surg Oncol; 1998; 5(3):253-60. PubMed ID: 9607628
[TBL] [Abstract][Full Text] [Related]
10. Differential gene expression profiling of primary cutaneous melanoma and sentinel lymph node metastases.
Koh SS; Wei JP; Li X; Huang RR; Doan NB; Scolyer RA; Cochran AJ; Binder SW
Mod Pathol; 2012 Jun; 25(6):828-37. PubMed ID: 22411186
[TBL] [Abstract][Full Text] [Related]
11. The tumor biology of melanoma nodal metastases.
Miliotes G; Albertini J; Berman C; Heller R; Messina J; Glass F; Cruse W; Rapaport D; Puleo C; Fenske N; Petsoglou C; Deconti R; Lyman G; Reintgen D
Am Surg; 1996 Jan; 62(1):81-8. PubMed ID: 8540654
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
[TBL] [Abstract][Full Text] [Related]
13. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
Fisher SR
Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
[TBL] [Abstract][Full Text] [Related]
14. Tumor Cell Adhesion As a Risk Factor for Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.
Meves A; Nikolova E; Heim JB; Squirewell EJ; Cappel MA; Pittelkow MR; Otley CC; Behrendt N; Saunte DM; Lock-Andersen J; Schenck LA; Weaver AL; Suman VJ
J Clin Oncol; 2015 Aug; 33(23):2509-15. PubMed ID: 26150443
[TBL] [Abstract][Full Text] [Related]
15. Regional lymph node dissections in malignant melanoma.
Lawton GP; Ariyan S
Clin Plast Surg; 2000 Jul; 27(3):431-40, ix. PubMed ID: 10941563
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound mapping of lymph node and subcutaneous metastases in patients with cutaneous melanoma: results of a prospective multicenter study.
Blum A; Schmid-Wendtner MH; Mauss-Kiefer V; Eberle JY; Kuchelmeister C; Dill-Müller D
Dermatology; 2006; 212(1):47-52. PubMed ID: 16319474
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
18. The role of elective lymph node dissection in the management of patients with thick cutaneous melanoma.
Crowley NJ; Seigler HF
Cancer; 1990 Dec; 66(12):2522-7. PubMed ID: 2249194
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
Essner R; Scheri R; Kavanagh M; Torisu-Itakura H; Wanek LA; Morton DL
Arch Surg; 2006 Sep; 141(9):877-82; discussion 882-4. PubMed ID: 16983031
[TBL] [Abstract][Full Text] [Related]
20. Beta3 integrin expression in melanoma predicts subsequent metastasis.
Hieken TJ; Farolan M; Ronan SG; Shilkaitis A; Wild L; Das Gupta TK
J Surg Res; 1996 Jun; 63(1):169-73. PubMed ID: 8661192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
